Literature DB >> 10627534

Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

H Ishida1, K Ueda, K Ohkawa, Y Kanazawa, A Hosui, F Nakanishi, E Mita, A Kasahara, Y Sasaki, M Hori, N Hayashi.   

Abstract

Hepatitis B virus (HBV) enhancer II (EnII) is a hepatotropic cis element which is responsible for the hepatocyte-specific gene expression of HBV. Multiple transcription factors have been demonstrated to interact with this region. In this study, the region from HBV nucleotides (nt) 1640 to 1663 in EnII was demonstrated to be essential for enhancer activity and to be another target sequence of putative transcription factors. To elucidate the factors which bind to this region, we used a yeast one-hybrid screening system and cloned three transcription factors, HLF, FTF, and E4BP4, from a human adult liver cDNA library. All of these factors had binding affinity to the sequence from nt 1640 to 1663. Investigation of the effects of these factors on transcriptional regulation revealed that HLF and FTF had stimulatory activity on nt 1640 to 1663, whereas E4BP4 had a suppressing effect. FTF coordinately activated both 3. 5-kb RNA and 2.4/2.1-kb RNA transcription in a transient transfection assay with an HBV expression vector. HLF, however, activated only 3.5-kb RNA transcription, and in primer extension analysis, HLF strongly stimulated the synthesis of pregenome RNA compared to precore RNA. Thus, FTF stimulated the activity of the second enhancer, while HLF stimulated the activity of the core upstream regulatory sequence, which affects only the core promoter, and had a dominant effect on the pregenome RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627534      PMCID: PMC111458          DOI: 10.1128/jvi.74.3.1241-1251.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4.

Authors:  C K Lai; L P Ting
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Authors:  R P Beasley; L Y Hwang; C C Lin; C S Chien
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

3.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

4.  The gene S promoter of hepatitis B virus confers constitutive gene expression.

Authors:  Y Malpièce; M L Michel; G Carloni; M Revel; P Tiollais; J Weissenbach
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

6.  Signals regulating hepatitis B surface antigen transcription.

Authors:  R Cattaneo; H Will; N Hernandez; H Schaller
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

7.  Cloning and characterization of a novel human hepatocyte transcription factor, hB1F, which binds and activates enhancer II of hepatitis B virus.

Authors:  M Li; Y H Xie; Y Y Kong; X Wu; L Zhu; Y Wang
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

8.  Transcription of the hepatitis B surface antigen gene in cultured murine cells initiates within the presurface region.

Authors:  D N Standring; W J Rutter; H E Varmus; D Ganem
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  Hepatitis B virus transcription in the infected liver.

Authors:  R Cattaneo; H Will; H Schaller
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

10.  A human hepatitis B viral enhancer element.

Authors:  Y Shaul; W J Rutter; O Laub
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  19 in total

1.  Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis.

Authors:  Farzaneh Salarnia; Sima Besharat; Sare Zhand; Naeme Javid; Behnaz Khodabakhshi; Abdolvahab Moradi
Journal:  J Clin Diagn Res       Date:  2017-03-01

2.  The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1.

Authors:  S Gilbert; L Galarneau; A Lamontagne; S Roy; L Bélanger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.

Authors:  Ya-Ju Hsieh; Fu-Du Chen; Chien-Chih Ke; Hsin-Ell Wang; Chih-Jen Huang; Ming-Feng Hou; Kang-Ping Lin; Juri G Gelovani; Ren-Shyan Liu
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

4.  Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo.

Authors:  Vanessa C Reese; David D Moore; Alan McLachlan
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.

Authors:  Shintaro Kamizono; Gordon S Duncan; Markus G Seidel; Akira Morimoto; Koichi Hamada; Gerard Grosveld; Koichi Akashi; Evan F Lind; Jillian P Haight; Pamela S Ohashi; A Thomas Look; Tak W Mak
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

6.  Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development.

Authors:  Vanessa Reese; Caitlin Ondracek; Christel Rushing; Lie Li; Claudia E Oropeza; Alan McLachlan
Journal:  Int J Biochem Cell Biol       Date:  2009-11-24       Impact factor: 5.085

Review 7.  Roles of hepatocyte nuclear factors in hepatitis B virus infection.

Authors:  Doo Hyun Kim; Hong Seok Kang; Kyun-Hwan Kim
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

8.  Peroxisome proliferator-activated receptor gamma Coactivator 1alpha and small heterodimer partner differentially regulate nuclear receptor-dependent hepatitis B virus biosynthesis.

Authors:  Caitlin R Ondracek; Christel N Rushing; Vanessa C Reese; Claudia E Oropeza; Alan McLachlan
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

9.  Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.

Authors:  Zhenhuan Zhao; Wei Hong; Zhengyang Zeng; Yingliang Wu; Kanghong Hu; Xiaohui Tian; Wenxin Li; Zhijian Cao
Journal:  J Biol Chem       Date:  2012-07-12       Impact factor: 5.157

10.  β-Catenin Signaling Regulates the In Vivo Distribution of Hepatitis B Virus Biosynthesis across the Liver Lobule.

Authors:  Grant Tarnow; Alan McLachlan
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.